⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 31/01/22 | 14:30:02 | 31 Jan 2022 | Exercise of Options and Total Voting Rights | |
| 25/01/22 | 07:00:06 | 25 Jan 2022 | Grant of share options | |
| 24/01/22 | 07:00:14 | 24 Jan 2022 | Clinical and commercial opportunity of NTCD-M3 | |
| 21/01/22 | 07:15:21 | 21 Jan 2022 | Destiny Pharma Lancet Report | |
| 17/01/22 | 07:00:07 | 17 Jan 2022 | Strategy/Company/Ops Update | |
| 21/12/21 | 16:35:06 | 21 Dec 2021 | Exercise of Options and Total Voting Rights | |
| 17/12/21 | 09:46:38 | 17 Dec 2021 | Grant of share options | |
| 15/11/21 | 14:26:42 | 15 Nov 2021 | Directorate Change | |
| 04/11/21 | 07:00:05 | 4 Nov 2021 | SAB Member Prof. Gerding is Keynote at C.diff Conf | |
| 18/10/21 | 07:00:05 | 18 Oct 2021 | Study gives strong support for potential of XF-73 | |
| 27/09/21 | 15:18:17 | 27 Sept 2021 | Director/PDMR Shareholding | |
| 27/09/21 | 07:00:06 | 27 Sept 2021 | Expansion of clinical pipeline | |
| 09/09/21 | 07:00:01 | 9 Sept 2021 | Interim results for six months ended 30 June 2021 | |
| 23/08/21 | 07:00:05 | 23 Aug 2021 | Notice of Interim Results |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 31/01/22 | 14:30:02 | 31 Jan 2022 | Exercise of Options and Total Voting Rights | |
| 25/01/22 | 07:00:06 | 25 Jan 2022 | Grant of share options | |
| 24/01/22 | 07:00:14 | 24 Jan 2022 | Clinical and commercial opportunity of NTCD-M3 | |
| 21/01/22 | 07:15:21 | 21 Jan 2022 | Destiny Pharma Lancet Report | |
| 17/01/22 | 07:00:07 | 17 Jan 2022 | Strategy/Company/Ops Update | |
| 21/12/21 | 16:35:06 | 21 Dec 2021 | Exercise of Options and Total Voting Rights | |
| 17/12/21 | 09:46:38 | 17 Dec 2021 | Grant of share options | |
| 15/11/21 | 14:26:42 | 15 Nov 2021 | Directorate Change | |
| 04/11/21 | 07:00:05 | 4 Nov 2021 | SAB Member Prof. Gerding is Keynote at C.diff Conf | |
| 18/10/21 | 07:00:05 | 18 Oct 2021 | Study gives strong support for potential of XF-73 | |
| 27/09/21 | 15:18:17 | 27 Sept 2021 | Director/PDMR Shareholding | |
| 27/09/21 | 07:00:06 | 27 Sept 2021 | Expansion of clinical pipeline | |
| 09/09/21 | 07:00:01 | 9 Sept 2021 | Interim results for six months ended 30 June 2021 | |
| 23/08/21 | 07:00:05 | 23 Aug 2021 | Notice of Interim Results |